Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers in Clozapine-responding Schizophrenia
NCT05316883Phase 4Recruiting
- Start
- Feb 2021
- Primary completion
- Dec 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of clozapine in schizophrenia, psychosis. Started Feb 2021; status: recruiting.
02
Drugs
clozapine
03
Conditions
schizophreniapsychosis
Beyond the preview
Go deeper on NCT05316883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05316883.